Home ROVI announces completion of the Clinical Trial Program that will support the application for marketing authorization for Doria® for the treatment of schizophrenia

ROVI announces completion of the Clinical Trial Program that will support the application for marketing authorization for Doria® for the treatment of schizophrenia

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact

Español

Read time: 0 mins

https://rovi.es/sites/default/files/PR_Doria_0.pdf

Year:

2019

ROVI announces completion of the Clinical Trial Program that will support the application for marketing authorization for Doria® for the treatment of schizophrenia

What is a "cookie"?

What types of cookies exist?

Who is responsible for the management of cookies on this Website?

What cookies are used by this Website and what are they used for?

How long are cookies stored for?

What is the legal basis for using cookies?

To whom will the cookies be communicated and who can access them?

What rights exist in relation to the use of cookies by this website?

How can I manage cookies?

A) FORM FOR EXERCISE OF RIGHT OF ACCESS

Particulars of applicant:

He/she requests:

B) FORM FOR EXERCISE OF RIGHT TO RECTIFICATION

Particulars of applicant:

He/she requests:

C) FORM FOR EXERCISE OF THE RIGHT TO ERASURE

Particulars of applicant:

He/she requests:

Reasons for erasure:

D) FORM FOR EXERCISE OF THE RIGHT TO RESTRICTION OF PROCESSING

Particulars of applicant:

He/she requests:

E) FORM FOR EXERCISE OF THE RIGHT TO DATA PORTABILITY

Particulars of applicant:

He/she requests:

F) FORM FOR EXERCISE OF THE RIGHT TO OBJECT

Particulars of applicant:

He/she requests: